OneMedPlace has announced that the first OneMedForum New York 2010 successfully brought together a promising group of 70 private and microcap companies in 25 different healthcare sectors with a prominent group of investors. The OneMedForum was recognized by Michael R. Bloomberg, Mayor of New York City, as an important event supporting innovation in the healthcare and life science industries “giving them the support, guidance and information they need to raise capital and develop innovative new ideas,” Bloomberg proclaimed June 29-30 in the city of New York as “OneMedForum Days.”
“We are appreciative of the recognition from the Mayor Bloomberg. The expansion of the bio sciences in New York has been an important initiative for the Mayor. This event, which brings the most promising companies and technologies from around the world for an annual summit in New York, is an important development for the city and building its healthcare and life sciences,” said Brett Johnson, CEO of OneMedPlace. “The enthusiastic response of over 300 attendees illustrates the value and overall impact of this conference,” he added.
Investors and companies from Australia, Switzerland, the Netherlands, Israel, Ireland, the UK, Germany, and France attended the OneMedForum New York 2010. The goal of the conference is to connect the most promising emerging healthcare and life sciences companies with investors and strategic partners, as well as provide New York’s leading research hospitals and universities an opportunity to showcase their best innovation technologies.The feedback from participants was considerable:
“I have been to no less than 4 congress in the last nine months and I have to say that I have gotten more out of this meeting in two days than I have in the last year and a half for the others. We have gotten 4 contacts that are very promising,” said Roger Kolasinski, President & CEO at NuVue Therapeutics.
“We got contacts and interest from 17 investors, VC, Investment Banks and Angel Groups,” said Gitte Pedersen, CEO of Genomic Expression Inc. “I’ve met very interesting companies, the panels are interesting, [and I] met many VCs that we can collaborate with,” said Elka Nir from Giza Venture Capital, managing partner of the leading Israeli Venture fund. “I saw many medical devices companies that seemed to be interesting in the space of cardiology.”
“It’s been a great day for me because I’ve had the chance to meet some talented, smart people, who are investors and strategic companies in the industry of orthopedics who are interested in learning more about the technologies and changing patterns and trends,”said Tony Viscogliosi, President at Small Bone Innovations, which is one of the most successful venture backed life sciences companies.
“Your NYC conference was great. I ran into some friends I knew as well as made some interesting new healthcare contacts. Also, I received interest from several traditional and non-traditional investors, both at the conference as well as one who followed up later. I look forward to your next conference,” said Shan Padda, CEO of Health Integrated.
“I believe it was a great forum. Had the chance to talk to some prospective investors; we are currently closing an A round of financing…. but we are about to start our B round and we talked to some investment bankers, some venture capital firms and some angel investors,” said Brian A. Leuthner, President & CEO at Edge Therapeutics.
Companies that presented at the OneMedForum New York: Abviva, Access Pharmaceuticals, AcuMEMS, AMT, AntriaBio, Arstasis, Axial Biotech, Biomoda, BioNanomatrix, Biovista Inc., The Brain Resources Company, Caleco Pharma Corp., Calibra Medical, Cardiogenesis Corporation, CeQur, CyberHeart Incorporated, Cytochroma Inc., DARA BioSciences, DataPhysics Research, DATATRAK International, DermDx, DiFUSION Technologies Inc., Echo Therapeutics, Edge Therapeutics, Eleison Pharmaceuticals, EpiCept Corporation, Exact Cost, Facet Solutions, Flexible Stenting Solutions, Health Integrated, HiLin Life Products, Insite Medical, LL Tech, Lucid, MacuCLEAR Inc., MedicaSafe, Morris Innovative Research, Myconostica, Nanobiotix, NeoMatrix, NewCardio, NuVue Therapeutics, PAION, PDS Biotechnology Co., PearlDiver, Pressure BioSciences, Principio, Inc., QuantRX Biomedical, RepRegen Ltd., S.E.A. Medical Systems, Silver Bullet Therapeutics, Sound Surgical Technologies LLC, T2 Biosystems, Tagent, Transdel Pharmaceuticals, Trigeminal Solutions, Unity Medical, Urologix, Urovalve, US HIFU LLC, Vasonova, Vaxin, VetCentric, Vyteris Inc. and Xlumena.
The OneMedForum NewYork was created to complement the West Coast OneMedForum held every January in San Francisco, which has become an important gathering point for companies and investors. The San Francisco Conference will include sessions on entering the Asian markets and will be held January 11-13, 2011.
Companies invited to present at the OneMedForums are recommended by Advisory board members with scientific, medical, regulatory, and financial expertise. Conference sponsors included Switzerland-based Gershon Capital and Stifel Nicolaus. Stifel was recently ranked #1 overall out of 183 qualifying firms in The Wall Street Journal’s Best on the Street Survey for 2010. The firm recently merged with Thomas Weisel Partners Group, Inc, which now provides research coverage of more companies than any other investment bank.
For more information about OneMedForums, visit http://www.onemedplace.com.